AU2002221261A1 - Method, antigen and antibody for distinguishing viable and apoptotic cells - Google Patents

Method, antigen and antibody for distinguishing viable and apoptotic cells

Info

Publication number
AU2002221261A1
AU2002221261A1 AU2002221261A AU2002221261A AU2002221261A1 AU 2002221261 A1 AU2002221261 A1 AU 2002221261A1 AU 2002221261 A AU2002221261 A AU 2002221261A AU 2002221261 A AU2002221261 A AU 2002221261A AU 2002221261 A1 AU2002221261 A1 AU 2002221261A1
Authority
AU
Australia
Prior art keywords
antigen
antibody
apoptotic cells
distinguishing viable
viable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221261A
Inventor
Mehmet Ozturk
Berna Suat Sayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002221261A1 publication Critical patent/AU2002221261A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002221261A 2001-11-22 2001-11-22 Method, antigen and antibody for distinguishing viable and apoptotic cells Abandoned AU2002221261A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2001/000060 WO2003044535A1 (en) 2001-11-22 2001-11-22 Method, antigen and antibody for distinguishing viable and apoptotic cells

Publications (1)

Publication Number Publication Date
AU2002221261A1 true AU2002221261A1 (en) 2003-06-10

Family

ID=21619337

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221261A Abandoned AU2002221261A1 (en) 2001-11-22 2001-11-22 Method, antigen and antibody for distinguishing viable and apoptotic cells

Country Status (2)

Country Link
AU (1) AU2002221261A1 (en)
WO (1) WO2003044535A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110850067B (en) * 2018-08-21 2023-08-15 上海恒润达生生物科技股份有限公司 Chimeric antigen receptor affinity detection method
CN110672499B (en) * 2019-09-29 2021-12-10 杭州联科生物技术股份有限公司 Positive quality control liquid for Annexin V apoptosis detection and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives
WO1998049325A1 (en) * 1997-04-28 1998-11-05 Mcgill University Reporter fusion proteins, expression vectors and transfected cell lines thereof for the analysis of nuclear transport
EP1149067B1 (en) * 1998-12-17 2004-02-25 F. Hoffmann-La Roche Ag 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents

Also Published As

Publication number Publication date
WO2003044535A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2002351623A1 (en) Streptococcus antigens
AU2001256755A1 (en) Biosensor and method for manufacturing the same
AU2002365649A1 (en) Anti-dota antibody
AU2002224066A1 (en) Aligner, aligning method and method for fabricating device
EP1581096A3 (en) Antigen pipa and antibodies that bind thereto
AU2003302235A1 (en) Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
AU2003302165A1 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
AU1301801A (en) Illuminator, aligner, and method for fabricating device
AU2002217212A1 (en) Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof
AU2002306748A1 (en) Anti-gpe antibodies, their uses, and analytical methods for gpe
AU2003237332A1 (en) Anti-relp fusion antibodies, compositions, methods and uses
AU2003244237A1 (en) Monoclonal antibody against adiponectin, preparation method and use thereof
AU2002221261A1 (en) Method, antigen and antibody for distinguishing viable and apoptotic cells
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
EP1279953A3 (en) Device and method for the separation within samples
AU2002365187A1 (en) Epitope synchronization in antigen presenting cells
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2003271093A1 (en) Antigen recognizing antibody
AU2002365925A1 (en) Rsv proteins, antibodies, compositions, methods and uses
AU2002302410A1 (en) Method for identifying immune reactive epitopes on proteins
AUPR666701A0 (en) Structural framework, method for forming the framework and webs therefor
AU2002231806A1 (en) H. influenzae antigen basb213
AU1443900A (en) Glycoprotein antigens, antibodies specific thereto and method for producing same
AU2003247216A1 (en) Novel sphinogmyelinase, the antibody against it, the antisense and the preparation method thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase